Beijing Zhongsheng Jinyu Diagnosis Technology Co., Ltd.
Similar suppliers you may like
Beijing Mygenostics Co., Ltd.
🇨🇳 China
2011501-1000 peopleManufacturer/Service CompanyHigh capacity factory
High-tech enterprise
Patented technology
Low MOQ
Key market
Europe
Description
Beijing Mygenostics Co., Ltd. is a leading high-tech biotechnology manufacturer and service provider established in 2011. Headquartered in Beijing with a 10,000-square-meter research and medical laboratory facility, the company also operates a wholly-owned subsidiary in Chongqing. With a workforce of over 750 employees, Mygenostics specializes in the R&D, production, and marketing of molecular diagnostics products, IVD devices, and comprehensive genomic solutions. The company is recognized for its patented GenCap™ technology, which enhances next-generation sequencing (NGS) by capturing both strands of genomic target regions to improve accuracy and reduce costs.
Their extensive product portfolio includes automated liquid handlers, nucleic acid extraction systems and kits, PCR kits, and specimen collection solutions. They also provide automated pipetting systems, microplate washers, and laboratory plastics. Mygenostics serves the scientific research, clinical, and diagnostic industries, offering OEM services and technical support. The company maintains high quality standards with ISO 13485 and FSC certifications. Since 2021, they have expanded their international trade footprint, exporting to Europe, the Middle East, South America, Africa, and Southeast Asia. Their technical excellence is supported by collaborations with prestigious universities and hospitals globally, contributing to over 450 scientific research papers and conducting more than 170,000 clinical tests.
Baby Care Kit$12.99
Capitalbio Technology Co., Ltd.
🇨🇳 China
101-200 peopleManufacturer/Service CompanyHigh-tech enterprise
Low MOQ
Shipments
127
Key customer
DOIT
Key market
🇻🇳 Vietnam
Description
Capitalbio Technology Co., Ltd. is a contract manufacturer and service company based in Beijing, China, operating as the industrialization platform of the CapitalBio Corporation and the Beijing National Engineering Research Center for Biochips. Established with 101 to 200 employees, the company integrates R&D, production, sales, and third-party independent medical laboratory services. Capitalbio Technology specializes in genetic detection and microarray technology, offering products such as Ngs Mutation Detection, Cnv-Seq Detection, Capitalbio® Microarray Scanner Luxscan™ 10K/D, Capitalbio® DNA Microarray Scanner Luxscan™ 10K, and Capitalbio® Microarray Hybridization Station. They also provide comprehensive genetic testing services, including those for hereditary cancers (e.g., BRCA1/2), blood cancer, and folic acid utilization ability. The company emphasizes independent innovation and achievement transformation, aligning with national health policies by integrating modern and traditional Chinese medicine to form a broad health industry section.
Genetic Testing of 18 Hereditary Cancer$10
Forensic Platform$10
Genetic Testing for Blood Cancer$10
Genetic Testing for Brca1/2 Targeted-Drug Guidance [ Germline + Somatic]$10
Genetic Testing for Hereditary Breast/Ovarian Cancer (BRCA1/2)$10
Folic Acid Utilization Ability Genetic Detection$10
